Comparison results
| Results: Differences General | ✘Skin dystrophy | ✘Neurofibromatosis | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| multiple warts | 91% | — | ||||||||||
| heel spur | — | 96% | ||||||||||
| dark eyes | 79% | — | ||||||||||
| bone growths on the legs | — | 93% | ||||||||||
| black acanthosis | 39% | — | ||||||||||
| nose bruises easily appear | — | 81% | ||||||||||
| skin dystrophy | 61% | 26% | ||||||||||
| convulsions | — | 79% | ||||||||||
| skin aging | 32% | — | ||||||||||
| bone growths | — | 75% | ||||||||||
| black discharge | 31% | — | ||||||||||
| varicose veins of the legs | — | 71% | ||||||||||
| oily skin | 30% | — | ||||||||||
| bruise | — | 70% | ||||||||||
| rashes in the folds of the skin | 29% | — | ||||||||||
| venous mesh on legs | — | 70% | ||||||||||
| reduced sweating | 29% | — | ||||||||||
| skin compaction | — | 70% | ||||||||||
| hypoxia | 28% | — | ||||||||||
| veins swelling on the legs | — | 68% | ||||||||||
| rash on the neck | 27% | — | ||||||||||
| recklinghausen 's neurofibromatosis | — | 68% | ||||||||||
| impaired arterial function | 25% | — | ||||||||||
| cramps in the legs | — | 67% | ||||||||||
| thin skin | 25% | — | ||||||||||
| neurinoma | — | 63% | ||||||||||
| common rashes | 24% | — | ||||||||||
| veins bloating | — | 63% | ||||||||||
| lowered | 23% | — | ||||||||||
| neurofibroma | — | 57% | ||||||||||
| the skin is dark | 23% | — | ||||||||||
| impaired venous function | — | 54% | ||||||||||
| better to be alone | 20% | — | ||||||||||
| cns tumors | — | 47% | ||||||||||
| skin problems | 38% | 23% | ||||||||||
| wilms ' tumor | — | 46% | ||||||||||
| history of surgery | 23% | 15% | ||||||||||
| brain cancer | — | 44% | ||||||||||
| blood diseases | 24% | 16% | ||||||||||
| meningioma | — | 44% | ||||||||||
| milk rashes | — | 41% | ||||||||||
| ependymoma of the brain | — | 39% | ||||||||||
| glioma | — | 38% | ||||||||||
| brain tumors | — | 37% | ||||||||||
| oncology | — | 36% | ||||||||||
| optic nerve glioma | — | 35% | ||||||||||
| skin spots | — | 35% | ||||||||||
| benign neoplasms | — | 34% | ||||||||||
| neuroblastoma | — | 33% | ||||||||||
| kidney sarcoma | — | 32% | ||||||||||
| astrocytoma | — | 31% | ||||||||||
| kidney cancer | — | 29% | ||||||||||
| thin-boned | — | 27% | ||||||||||
| problems with the father | — | 27% | ||||||||||
| rashes symmetrical | — | 26% | ||||||||||
| cancer | — | 25% | ||||||||||
| false joint | — | 24% | ||||||||||
| leukemia | — | 23% | ||||||||||
| no joints | — | 23% | ||||||||||
| heavy weight | — | 23% | ||||||||||
| history medical mother's | — | 23% | ||||||||||
| cataract | — | 22% | ||||||||||
| brown pigmentation after rashes | — | 22% | ||||||||||
| brown spots on the skin | — | 22% | ||||||||||
| diseases of infants | — | 22% | ||||||||||
| s eyes cloudy | — | 21% | ||||||||||
| epilepsy attacks | — | 21% | ||||||||||
| lymphosarcoma | — | 21% | ||||||||||
| consequences of pregnancy | — | 20% | ||||||||||
| epilepsy | — | 20% | ||||||||||
| traumatic illness | — | 20% | ||||||||||
| impaired kidney function | — | 18% | ||||||||||
| damage to the nervous system | — | 17% | ||||||||||
| childhood diseases | — | 17% | ||||||||||
| increased | — | 15% | ||||||||||
| spinal meningioma | — | 15% | ||||||||||
Instructions
Video
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.